Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2017

Open Access 01-04-2017 | Epidemiology

Quantification of masking risk in screening mammography with volumetric breast density maps

Authors: Katharina Holland, Carla H. van Gils, Ritse M. Mann, Nico Karssemeijer

Published in: Breast Cancer Research and Treatment | Issue 3/2017

Login to get access

Abstract

Purpose

Fibroglandular tissue may mask breast cancers, thereby reducing the sensitivity of mammography. Here, we investigate methods for identification of women at high risk of a masked tumor, who could benefit from additional imaging.

Methods

The last negative screening mammograms of 111 women with interval cancer (IC) within 12 months after the examination and 1110 selected normal screening exams from women without cancer were used. From the mammograms, volumetric breast density maps were computed, which provide the dense tissue thickness for each pixel location. With these maps, three measurements were derived: (1) percent dense volume (PDV), (2) percent area where dense tissue thickness exceeds 1 cm (PDA), and (3) dense tissue masking model (DTMM). Breast density was scored by a breast radiologist using BI-RADS. Women with heterogeneously and extremely dense breasts were considered at high masking risk. For each masking measure, mammograms were divided into a high- and low-risk category such that the same proportion of the controls is at high masking risk as with BI-RADS.

Results

Of the women with IC, 66.1, 71.9, 69.2, and 63.0% were categorized to be at high masking risk with PDV, PDA, DTMM, and BI-RADS, respectively, against 38.5% of the controls. The proportion of IC at high masking risk is statistically significantly different between BI-RADS and PDA (p-value 0.022). Differences between BI-RADS and PDV, or BI-RADS and DTMM, are not statistically significant.

Conclusion

Measures based on density maps, and in particular PDA, are promising tools to identify women at high risk for a masked cancer.
Appendix
Available only for authorised users
Literature
1.
4.
go back to reference Nederend J, Duijm LEM, Louwman MWJ et al (2014) Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment—a population based study from the Netherlands. Eur J Cancer 50:31–39. doi:10.1016/j.ejca.2013.09.018 CrossRefPubMed Nederend J, Duijm LEM, Louwman MWJ et al (2014) Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment—a population based study from the Netherlands. Eur J Cancer 50:31–39. doi:10.​1016/​j.​ejca.​2013.​09.​018 CrossRefPubMed
5.
9.
go back to reference Destounis S, Johnston L, Highnam R et al (2016) Using volumetric breast density to quantify the potential masking risk of mammographic density. Am J Roentgenol 8:222–227. doi:10.2214/AJR.16.16489 Destounis S, Johnston L, Highnam R et al (2016) Using volumetric breast density to quantify the potential masking risk of mammographic density. Am J Roentgenol 8:222–227. doi:10.​2214/​AJR.​16.​16489
10.
go back to reference Kerlikowske K, Zhu W, Tosteson ANA et al (2015) Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Inter Med 162:673–681. doi:10.7326/M14-1465 CrossRef Kerlikowske K, Zhu W, Tosteson ANA et al (2015) Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Inter Med 162:673–681. doi:10.​7326/​M14-1465 CrossRef
11.
go back to reference Prummel MV, Muradali D, Shumak R et al (2016) Digital compared with screen-film mammography: measures of diagnostic accuracy among women screened in the Ontario breast screening program. Radiology 278:365–373. doi:10.1148/radiol.2015150733 CrossRefPubMed Prummel MV, Muradali D, Shumak R et al (2016) Digital compared with screen-film mammography: measures of diagnostic accuracy among women screened in the Ontario breast screening program. Radiology 278:365–373. doi:10.​1148/​radiol.​2015150733 CrossRefPubMed
19.
go back to reference Kim WH, Chang JM, Lee J et al (2017) Diagnostic performance of tomosynthesis and breast ultrasonography in women with dense breasts: a prospective comparison study. Breast Cancer Res Treat. doi:10.1007/s10549-017-4105-z Kim WH, Chang JM, Lee J et al (2017) Diagnostic performance of tomosynthesis and breast ultrasonography in women with dense breasts: a prospective comparison study. Breast Cancer Res Treat. doi:10.​1007/​s10549-017-4105-z
20.
go back to reference D’Orsi CJ, Bassett LW, Berg WA et al (2003) Breast imaging reporting and data system (BI-RADS) atlas, 4th edn. American College of Radiology, Reston D’Orsi CJ, Bassett LW, Berg WA et al (2003) Breast imaging reporting and data system (BI-RADS) atlas, 4th edn. American College of Radiology, Reston
21.
go back to reference D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA et al (2013) ACR BI-RADS atlas breast imaging reporting and data system. American College of Radiology, Reston D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA et al (2013) ACR BI-RADS atlas breast imaging reporting and data system. American College of Radiology, Reston
24.
25.
go back to reference Otten JDM, Karssemeijer N, Hendriks JHCL et al (2005) Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 97:748–754. doi:10.1093/jnci/dji131 CrossRefPubMed Otten JDM, Karssemeijer N, Hendriks JHCL et al (2005) Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 97:748–754. doi:10.​1093/​jnci/​dji131 CrossRefPubMed
26.
go back to reference Weber RJP, van Bommel RMG, Louwman MW et al (2016) Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography. Breast Cancer Res Treat 158:471–483. doi:10.1007/s10549-016-3882-0 CrossRefPubMed Weber RJP, van Bommel RMG, Louwman MW et al (2016) Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography. Breast Cancer Res Treat 158:471–483. doi:10.​1007/​s10549-016-3882-0 CrossRefPubMed
28.
29.
go back to reference Ekpo EU, Ujong UP, Mello-Thoms C, McEntee MF (2016) Assessment of interradiologist agreement regarding mammographic breast density classification using the fifth edition of the BI-RADS atlas. Am J Roentgenol 206:1119–1123. doi:10.2214/AJR.15.15049 CrossRef Ekpo EU, Ujong UP, Mello-Thoms C, McEntee MF (2016) Assessment of interradiologist agreement regarding mammographic breast density classification using the fifth edition of the BI-RADS atlas. Am J Roentgenol 206:1119–1123. doi:10.​2214/​AJR.​15.​15049 CrossRef
30.
33.
go back to reference Holland K, van Gils CH, Wanders JOP et al (2016) Quantification of mammographic masking risk with volumetric breast density maps: how to select women for supplemental screening. Med Imaging. doi:10.1117/12.2216810 Holland K, van Gils CH, Wanders JOP et al (2016) Quantification of mammographic masking risk with volumetric breast density maps: how to select women for supplemental screening. Med Imaging. doi:10.​1117/​12.​2216810
Metadata
Title
Quantification of masking risk in screening mammography with volumetric breast density maps
Authors
Katharina Holland
Carla H. van Gils
Ritse M. Mann
Nico Karssemeijer
Publication date
01-04-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4137-4

Other articles of this Issue 3/2017

Breast Cancer Research and Treatment 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine